Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 13902-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#13902-1-AP, RRID:AB_2086189
- Product name
- CXCL16 antibody
- Antibody type
- Polyclonal
- Description
- CXCL16 antibody (Cat. #13902-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references CXCL16 promotes tumor metastasis by regulating angiogenesis in the tumor micro-environment of BRAF V600E mutant colorectal cancer.
Serum CXCL16: A new predictor of liver inflammation in patients with chronic hepatitis B.
OVOL2 attenuates the expression of MAP3K8 to suppress epithelial mesenchymal transition in colorectal cancer.
Deng W, Liu X, Huang S, Wu Z, Alessandro F, Lin Q, Cai Z, Zhang Z, Huang Y, Wang H, Yuan Z
Translational oncology 2024 Mar;41:101854
Translational oncology 2024 Mar;41:101854
Serum CXCL16: A new predictor of liver inflammation in patients with chronic hepatitis B.
Wan Y, Mao M, Li M, Liu J, Tong X, Wang J, Li J, Yin S, Wu C
Journal of viral hepatitis 2024 Feb;31(2):107-119
Journal of viral hepatitis 2024 Feb;31(2):107-119
OVOL2 attenuates the expression of MAP3K8 to suppress epithelial mesenchymal transition in colorectal cancer.
Xia L, Gao J, Ma K, Lin H, Chen Y, Luo Q, Lian J
Pathology, research and practice 2021 Aug;224:153493
Pathology, research and practice 2021 Aug;224:153493
No comments: Submit comment
No validations: Submit validation data